JP2018052983A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018052983A5 JP2018052983A5 JP2017251017A JP2017251017A JP2018052983A5 JP 2018052983 A5 JP2018052983 A5 JP 2018052983A5 JP 2017251017 A JP2017251017 A JP 2017251017A JP 2017251017 A JP2017251017 A JP 2017251017A JP 2018052983 A5 JP2018052983 A5 JP 2018052983A5
- Authority
- JP
- Japan
- Prior art keywords
- blood
- metabolic syndrome
- subject
- mmol
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23327509P | 2009-08-12 | 2009-08-12 | |
| US61/233,275 | 2009-08-12 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017039099A Division JP6271785B2 (ja) | 2009-08-12 | 2017-03-02 | 代謝性症候群を予防し又は治療するための方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019073924A Division JP2019104768A (ja) | 2009-08-12 | 2019-04-09 | 代謝性症候群を予防し又は治療するための方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018052983A JP2018052983A (ja) | 2018-04-05 |
| JP2018052983A5 true JP2018052983A5 (cg-RX-API-DMAC7.html) | 2018-06-14 |
Family
ID=43586452
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012524836A Active JP5909182B2 (ja) | 2009-08-12 | 2010-08-11 | 代謝性症候群を予防し又は治療するための方法 |
| JP2015250186A Pending JP2016041762A (ja) | 2009-08-12 | 2015-12-22 | 代謝性症候群を予防し又は治療するための方法 |
| JP2017039099A Active JP6271785B2 (ja) | 2009-08-12 | 2017-03-02 | 代謝性症候群を予防し又は治療するための方法 |
| JP2017251017A Pending JP2018052983A (ja) | 2009-08-12 | 2017-12-27 | 代謝性症候群を予防し又は治療するための方法 |
| JP2019073924A Pending JP2019104768A (ja) | 2009-08-12 | 2019-04-09 | 代謝性症候群を予防し又は治療するための方法 |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012524836A Active JP5909182B2 (ja) | 2009-08-12 | 2010-08-11 | 代謝性症候群を予防し又は治療するための方法 |
| JP2015250186A Pending JP2016041762A (ja) | 2009-08-12 | 2015-12-22 | 代謝性症候群を予防し又は治療するための方法 |
| JP2017039099A Active JP6271785B2 (ja) | 2009-08-12 | 2017-03-02 | 代謝性症候群を予防し又は治療するための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019073924A Pending JP2019104768A (ja) | 2009-08-12 | 2019-04-09 | 代謝性症候群を予防し又は治療するための方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US20110039766A1 (cg-RX-API-DMAC7.html) |
| EP (4) | EP3251686A1 (cg-RX-API-DMAC7.html) |
| JP (5) | JP5909182B2 (cg-RX-API-DMAC7.html) |
| CN (3) | CN105031605A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2770688C (cg-RX-API-DMAC7.html) |
| DK (1) | DK2464371T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2576746T3 (cg-RX-API-DMAC7.html) |
| HK (1) | HK1247820A1 (cg-RX-API-DMAC7.html) |
| HU (1) | HUE029550T2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011019809A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102625709A (zh) | 2009-08-24 | 2012-08-01 | 康肽德生物医药技术有限公司 | 用于预防或治疗眼科病症的方法和组合物 |
| EP2764871A1 (en) * | 2009-10-05 | 2014-08-13 | Cornell University | Methods for the prevention or treatment of heart failure |
| US20130190244A1 (en) * | 2009-12-31 | 2013-07-25 | Stealth Peptides International, Inc. | Methods for performing a coronary artery bypass graft procedure |
| US9636378B2 (en) * | 2012-03-30 | 2017-05-02 | Stealth Biotherapeutics Corp | Methods and compositions for the prevention and treatment neuropathy |
| CN110090304A (zh) * | 2012-08-02 | 2019-08-06 | 康德生物医疗技术公司 | 用于治疗动脉粥样硬化的方法 |
| PE20151434A1 (es) * | 2012-10-22 | 2015-10-16 | Stealth Peptides Int Inc | Metodos para la reduccion de los riesgos asociados con el insuficiencia cardiaca y factores asociados con el mismo |
| WO2014088631A1 (en) * | 2012-12-06 | 2014-06-12 | Stealth Peptides International, Inc. | Peptide therapeutics and methods for using same |
| JP6839490B2 (ja) | 2013-03-01 | 2021-03-10 | ステルス バイオセラピューティックス コープ | ミトコンドリア疾患の治療のための方法 |
| CN115990241A (zh) | 2013-03-01 | 2023-04-21 | 康德生物医疗有限公司 | 预防或治疗巴斯综合征的方法和组合物 |
| US10047395B2 (en) | 2013-06-26 | 2018-08-14 | Stealth Biotherapeutics Corp | Methods and compositions for detecting and diagnosing diseases and conditions |
| US20170057995A1 (en) * | 2013-09-27 | 2017-03-02 | Cornell University | Use of aromatic-cationic peptides to treat cholesterol-induced mitochondrial dysfunction |
| CN105939759B (zh) * | 2013-12-02 | 2020-01-17 | 康德生物医疗技术公司 | 用于治疗白癜风的组合物和方法 |
| WO2017066659A1 (en) * | 2015-10-16 | 2017-04-20 | The Trustees Of Columbia University In The City Of New York | Jag1 expression predicts therapeutic response in nash |
| CN109563131A (zh) * | 2016-04-11 | 2019-04-02 | 卡诺有限责任公司 | 手性肽 |
| CN108210904A (zh) * | 2016-12-15 | 2018-06-29 | 深圳瑞健生命科学研究院有限公司 | 治疗动脉粥样硬化及其并发症的药物及其用途 |
| US11207387B2 (en) | 2016-12-15 | 2021-12-28 | Talengen International Limited | Method and drug for preventing and treating obesity |
| JP7214225B2 (ja) | 2016-12-15 | 2023-01-30 | タレンゲン インターナショナル リミテッド | 脂肪肝を予防および治療するための方法 |
| EP3771467A1 (en) | 2019-07-30 | 2021-02-03 | Fundacio Institut de Recerca de l'Hospital de la Santa Creu i sant Pau | Ss-31 for the prevention and/or treatment of aneurysm |
| CN117881411A (zh) | 2021-06-01 | 2024-04-12 | 艾迪雅生物有限责任公司 | 用于眼部药物的延长释放药物递送系统和使用方法 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5602100A (en) * | 1988-06-30 | 1997-02-11 | Astra Ab | Dermorphin analogs having pharmacological activity |
| ES2085865T3 (es) * | 1988-06-30 | 1996-06-16 | Astra Ab | Analogos de dermorfina, sus metodos de preparacion, composiciones farmaceuticas, y metodos de tratamiento terapeutico que los emplean. |
| US5674980A (en) * | 1989-12-21 | 1997-10-07 | Biogen Inc | Fusion protein comprising tat-derived transport moiety |
| US5858784A (en) | 1991-12-17 | 1999-01-12 | The Regents Of The University Of California | Expression of cloned genes in the lung by aerosol- and liposome-based delivery |
| US5716644A (en) * | 1992-06-11 | 1998-02-10 | Alkermes, Inc. | Composition for sustained release of non-aggregated erythropoietin |
| US5674534A (en) * | 1992-06-11 | 1997-10-07 | Alkermes, Inc. | Composition for sustained release of non-aggregated erythropoietin |
| US5468798A (en) * | 1994-02-18 | 1995-11-21 | Whitford Corporation | Basecoat for a coating system |
| DE69630918T2 (de) * | 1995-06-09 | 2004-10-28 | Hisamitsu Pharmaceutical Co., Inc., Tosu | Matrix für Iontophorese |
| US5849761A (en) * | 1995-09-12 | 1998-12-15 | Regents Of The University Of California | Peripherally active anti-hyperalgesic opiates |
| US5885958A (en) * | 1997-03-25 | 1999-03-23 | Administrators Of The Tulane Educational Fund | Mu-opiate receptor peptides |
| AU1818299A (en) * | 1997-12-10 | 1999-06-28 | Washington University | Anti-pathogen system and methods of use thereof |
| AU3965699A (en) * | 1998-04-24 | 1999-11-16 | Mitokor | Compounds and methods for treating mitochondria-associated diseases |
| SE9900961D0 (sv) * | 1999-03-16 | 1999-03-16 | Astra Ab | Novel compounds |
| CA2386239A1 (en) * | 1999-10-04 | 2001-04-12 | University Of Medicine And Dentistry Of New Jersey | Methods for identifying rna binding compounds |
| US6759520B1 (en) * | 1999-10-28 | 2004-07-06 | The New England Medical Center Hospitals, Inc. | Chimeric analgesic peptides |
| US20050192215A1 (en) * | 2000-01-21 | 2005-09-01 | Malabika Ghosh | Methods and materials relating to novel polypeptides and polynucleotides |
| DE60143945D1 (de) * | 2000-07-18 | 2011-03-10 | Cornell Res Foundation Inc | Medizinische verwendung von agonisten des mu-opioid rezeptors |
| US6900178B2 (en) * | 2000-09-12 | 2005-05-31 | University Of Kentucky Research Foundation | Protection against ischemia and reperfusion injury |
| US20070015146A1 (en) * | 2001-05-22 | 2007-01-18 | Gene Logic, Inc. | Molecular nephrotoxicology modeling |
| US7576061B2 (en) * | 2003-02-04 | 2009-08-18 | Cornell Research Foundation, Inc. | Methods for preventing mitochondrial permeability transition |
| DK2604285T3 (en) * | 2003-05-01 | 2014-12-01 | Cornell Res Foundation Inc | Method and carrier complex for delivering molecules to cells |
| WO2005032481A2 (en) * | 2003-09-30 | 2005-04-14 | Scios Inc. | Quinazoline derivatives as medicaments |
| EP1699476A1 (en) * | 2003-11-28 | 2006-09-13 | DeveloGen Aktiengesellschaft | Method for preventing and treating diabetes using dg119 |
| NZ549393A (en) * | 2004-01-23 | 2009-07-31 | Cornell Res Foundation Inc | Methods for reducing oxidative damage |
| EP1734963A4 (en) * | 2004-04-02 | 2008-06-18 | Merck & Co Inc | METHOD FOR TREATING PEOPLE WITH METABOLIC AND ANTHROPOMETRIC DISORDER |
| US20050272101A1 (en) * | 2004-06-07 | 2005-12-08 | Prasad Devarajan | Method for the early detection of renal injury |
| US7541340B2 (en) * | 2005-09-16 | 2009-06-02 | Cornell Research Foundation, Inc. | Methods for reducing CD36 expression |
| US20070259377A1 (en) * | 2005-10-11 | 2007-11-08 | Mickey Urdea | Diabetes-associated markers and methods of use thereof |
| US20080027082A1 (en) * | 2006-06-19 | 2008-01-31 | Berthold Hocher | Use of adenosine a1 antagonists in radiocontrast media induced nephropathy |
| US20080161400A1 (en) * | 2006-10-26 | 2008-07-03 | Xenoport, Inc. | Use of forms of propofol for treating diseases associated with oxidative stress |
| JP5453320B2 (ja) * | 2008-02-07 | 2014-03-26 | コーネル ユニヴァーシティー | インスリン抵抗性を防止または処置するための方法 |
| EP3741381B1 (en) * | 2008-02-26 | 2024-04-24 | Cornell University | A peptide for use for prevention and treatment of acute renal injury |
| EP2764871A1 (en) * | 2009-10-05 | 2014-08-13 | Cornell University | Methods for the prevention or treatment of heart failure |
-
2010
- 2010-08-11 CN CN201510230758.9A patent/CN105031605A/zh active Pending
- 2010-08-11 HU HUE10808688A patent/HUE029550T2/en unknown
- 2010-08-11 WO PCT/US2010/045160 patent/WO2011019809A1/en not_active Ceased
- 2010-08-11 DK DK10808688.5T patent/DK2464371T3/en active
- 2010-08-11 ES ES10808688.5T patent/ES2576746T3/es active Active
- 2010-08-11 CA CA2770688A patent/CA2770688C/en active Active
- 2010-08-11 US US12/854,551 patent/US20110039766A1/en not_active Abandoned
- 2010-08-11 EP EP17160557.9A patent/EP3251686A1/en not_active Withdrawn
- 2010-08-11 EP EP18175816.0A patent/EP3427746A1/en not_active Withdrawn
- 2010-08-11 EP EP10808688.5A patent/EP2464371B1/en active Active
- 2010-08-11 JP JP2012524836A patent/JP5909182B2/ja active Active
- 2010-08-11 CN CN201710423699.6A patent/CN107412724A/zh active Pending
- 2010-08-11 CN CN2010800461915A patent/CN102647994A/zh active Pending
- 2010-08-11 EP EP16150396.6A patent/EP3067061A1/en not_active Withdrawn
-
2015
- 2015-08-21 US US14/832,403 patent/US20160199435A1/en not_active Abandoned
- 2015-12-22 JP JP2015250186A patent/JP2016041762A/ja active Pending
-
2017
- 2017-03-02 JP JP2017039099A patent/JP6271785B2/ja active Active
- 2017-05-09 US US15/590,288 patent/US20180104304A1/en not_active Abandoned
- 2017-12-27 JP JP2017251017A patent/JP2018052983A/ja active Pending
-
2018
- 2018-06-01 HK HK18107245.8A patent/HK1247820A1/zh unknown
- 2018-08-09 US US16/100,105 patent/US20190209641A1/en not_active Abandoned
-
2019
- 2019-04-09 JP JP2019073924A patent/JP2019104768A/ja active Pending